Wang Yu-qin

529 total citations
17 papers, 421 citations indexed

About

Wang Yu-qin is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Wang Yu-qin has authored 17 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Hepatology. Recurrent topics in Wang Yu-qin's work include Hepatitis B Virus Studies (3 papers), Ginseng Biological Effects and Applications (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Wang Yu-qin is often cited by papers focused on Hepatitis B Virus Studies (3 papers), Ginseng Biological Effects and Applications (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Wang Yu-qin collaborates with scholars based in China, United Kingdom and Sweden. Wang Yu-qin's co-authors include Jian‐Gao Fan, Xingya Guo, Qin Pan, Fang Sun, Yongtao Xiao, Kun Guo, Wenxi Li, Ning Wang, André Steinmetz and William Jia and has published in prestigious journals such as Biochemical and Biophysical Research Communications, World Journal of Gastroenterology and Oxidative Medicine and Cellular Longevity.

In The Last Decade

Wang Yu-qin

17 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wang Yu-qin China 9 246 141 80 49 46 17 421
Yilin Yang China 13 375 1.5× 68 0.5× 154 1.9× 84 1.7× 44 1.0× 29 748
Yipeng Chen China 10 190 0.8× 125 0.9× 213 2.7× 120 2.4× 49 1.1× 12 491
Xiangyang Hu China 11 191 0.8× 47 0.3× 49 0.6× 31 0.6× 56 1.2× 17 519
Dingzhou Li United States 11 126 0.5× 40 0.3× 86 1.1× 25 0.5× 29 0.6× 33 473
Kai Hu China 14 268 1.1× 132 0.9× 58 0.7× 8 0.2× 30 0.7× 32 560
Ruiyu Li China 13 175 0.7× 88 0.6× 55 0.7× 14 0.3× 18 0.4× 45 478
Yue Dong China 13 316 1.3× 133 0.9× 65 0.8× 13 0.3× 36 0.8× 23 600
Asmaa Oun Netherlands 9 166 0.7× 32 0.2× 44 0.6× 21 0.4× 44 1.0× 14 395
Chunli Yin China 17 282 1.1× 76 0.5× 48 0.6× 7 0.1× 31 0.7× 29 541

Countries citing papers authored by Wang Yu-qin

Since Specialization
Citations

This map shows the geographic impact of Wang Yu-qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang Yu-qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang Yu-qin more than expected).

Fields of papers citing papers by Wang Yu-qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wang Yu-qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang Yu-qin. The network helps show where Wang Yu-qin may publish in the future.

Co-authorship network of co-authors of Wang Yu-qin

This figure shows the co-authorship network connecting the top 25 collaborators of Wang Yu-qin. A scholar is included among the top collaborators of Wang Yu-qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wang Yu-qin. Wang Yu-qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Yutuc, Eylan, Roberto Angelini, Neil P. Robertson, et al.. (2025). Sterol imbalances and cholesterol‐24‐hydroxylase dysregulation is linked to the underlying progression of multiple sclerosis. Brain Pathology. 35(5). e70001–e70001. 1 indexed citations
2.
Yu-qin, Wang, Zhiyuan Yao, Yuqi Li, et al.. (2024). Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy. World Journal of Gastroenterology. 30(37). 4132–4148. 2 indexed citations
3.
Yu-qin, Wang, et al.. (2024). Effect of Codonopsis pilosula polysaccharide on the quality of sheep semen preservation at 4°C. Animal Bioscience. 37(6). 1001–1006. 3 indexed citations
4.
Yu-qin, Wang, et al.. (2024). Rising government debt on the path of going green in China. Macroeconomic Dynamics. 29. 1 indexed citations
5.
Griffiths, William J., Jonas Abdel‐Khalik, Sarah F. Moore, et al.. (2021). The Cerebrospinal Fluid Profile of Cholesterol Metabolites in Parkinson’s Disease and Their Association With Disease State and Clinical Features. Frontiers in Aging Neuroscience. 13. 685594–685594. 10 indexed citations
6.
Ji, Wen, et al.. (2020). Crowd V-IoE: Visual Internet of Everything Architecture in AI-Driven Fog Computing. IEEE Wireless Communications. 27(2). 51–57. 24 indexed citations
7.
Li, Ling, Tong Zhang, Chunru Li, et al.. (2018). Potential therapeutic effects of <em>Cordyceps cicadae</em> and <em>Paecilomyces cicadae </em>on adenine-induced chronic renal failure in rats and their phytochemical analysis. Drug Design Development and Therapy. Volume 13. 103–117. 33 indexed citations
8.
Guo, Xingya, et al.. (2017). circRNA_0046367 Prevents Hepatoxicity of Lipid Peroxidation: An Inhibitory Role against Hepatic Steatosis. Oxidative Medicine and Cellular Longevity. 2017(1). 3960197–3960197. 95 indexed citations
9.
Huang, Xiu‐Feng, Dan Lin, Keng‐Hung Lin, et al.. (2016). Genotype-Phenotype Association Study Reveals CFI-Rs13104777 to be a Protective Genetic Marker Against Acute Anterior Uveitis. Ocular Immunology and Inflammation. 26(1). 51–56. 3 indexed citations
10.
Yan, Shiyan, Yi Zhang, Chao Sun, et al.. (2016). The clinical effect and relevant mechanism of combined sorafenib and radiofrequency ablation in the treatment of early small hepatocellular carcinoma. Oncology Letters. 12(2). 951–955. 8 indexed citations
12.
Han, Meihua, Jing Chen, Wang Yu-qin, Shilin Chen, & Xiangtao Wang. (2013). Determination of 20(S)-protopanaxadiol in rat plasma by LC-MS/MS and its application to the pharmacokinetic study: A comparative study of its solution and two oral formulations. Journal of Analytical Chemistry. 68(8). 730–735. 8 indexed citations
13.
Li, Wenxi, et al.. (2012). miR-181b Promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients. Biochemical and Biophysical Research Communications. 421(1). 4–8. 88 indexed citations
14.
Xu, Xiaole, Yanjuan Huang, Wang Yu-qin, Xiangfan Chen, & Wei Zhang. (2011). 2,3,4′,5‐Tetrahydroxystilbene‐2‐O‐β‐d‐glucoside inhibits platelet‐derived growth factor‐induced proliferation of vascular smooth muscle cells by regulating the cell cycle. Clinical and Experimental Pharmacology and Physiology. 38(5). 307–313. 22 indexed citations
15.
Wang, Qiong, Lihua Sun, William Jia, et al.. (2010). Comparison of ginsenosides Rg1 and Rb1 for their effects on improving scopolamine‐induced learning and memory impairment in mice. Phytotherapy Research. 24(12). 1748–1754. 104 indexed citations
16.
Liao, Yuhua, et al.. (2008). Effects of transplanted myoblasts transfected with human growth hormone gene on improvement of ventricular function of rats. Chinese Medical Journal. 121(4). 347–354. 13 indexed citations
17.
Gong, Xiao-hong, et al.. (2004). [Study on the afficacy of hepatitis B immunization among youngsters in Beijing].. PubMed. 25(5). 388–90. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026